4-juillet-2023
Français
4-juillet-2023
Français
4-juillet-2023
Français
28-June-2023
English
Report on the WNT Workshop how to prepare the Test Guidelines Programme for emerging technologies | In December 2022, the OECD held a workshop to explore where and how to adapt the Test Guidelines to emerging technologies, and remain relevant and impactful. A number of projects and activities are emanating from this workshop discussions, including the revision of Guidance Document 34 on validation, and more to come.
27-June-2023
English
Initial Recommendations on Evaluation of Data from the Developmental Neurotoxicity (DNT) In-Vitro Testing Battery | This document includes the lessons learned from the application of this technology in the field of pharmaceuticals and considers a range of issues directly relevant to human exposure arising from the application of externally-applied dsRNA-based pesticides, and discusses possible effects of dsRNA exposure in mammals.
11-October-2022
English
GLP issues raised by testing labs are covered in this comprehensive list of questions and answers, recently updated with questions related to: Test Facility organisation and personnel, Quality Assurance, Equipment and computerized systems, Test items, reference items and samples/specimens (Biologicals, GMOs, etc.), SOPs, Management of the study, Histopathology, Archives and E-Archives and Monitoring Test Facility compliance by GLP CMAs.
30-juin-2022
Français
17-juin-2021
Français
2-March-2021
English
As the demand for safer chemicals grows, the field of alternatives assessment is becoming increasingly important in guiding the transition towards safer, less toxic alternatives. A major limitation that can hinder efforts is the lack of consistent criteria for defining “safer" alternatives. This guidance outlines key considerations for the identification and selection of safer alternatives.
17-February-2021
English, PDF, 1,537kb